Study on the Mechanism of m6A Modification in Atherosclerosis

Corresponding author: cuiyuhong, 18567367709@163.com

DOI: 10.12201/bmr.202412.00056

•  

  Abstract: [abstract missed]

  Key words: ; ; ; 

  Submit time: 24 December 2024

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• ZHU yan, ZHENG Jie, Li Xiaoying, Yang Xiaolin, HE Yongqun. Introduction to Basic Formal Ontology and its Chinese Translation. 2020. doi: 10.12201/bmr.202007.00009

  Lee. Research progress of Chinese Medicine in the prevention and treatment of atherosclerotic vulnerable plaque by the regulation of macrophage polarization. 2020. doi: 10.12201/bmr.202004.00005

  wangyifan, shichaojun, maanning. Comparison of risk prediction models for atherosclerosis in type 2 diabetes mellitus. 2024. doi: 10.12201/bmr.202404.00007

  Tong Mingfu. Correlation between Triglyceride Glucose-body Mass Index, Atherogenic Index of Plasma and Gallstone Disease. 2024. doi: 10.12201/bmr.202411.00068

  shenzhouji, guofei. Research progress of histone modification and DNA methylation in diabetes nephropathy. 2024. doi: 10.12201/bmr.202407.00011

  lixin, panbinbin, wangpeng, lufeife. . 2024. doi: 10.12201/bmr.202408.00035

  heyanping, zhangxiaodan, yaoqiang. The health effect and mechanism of family doctor contract service: Evidence from 1 191 rural residents with chronic disease in 12 counties of 6 provinces. 2024. doi: 10.12201/bmr.202409.00051

  Zhang Han, Chu Mengyuan, Xu Kaikai, Xiang Xin, Yan Ying. Progress in Mechanism of Action of Isthmin1 Protein in Polycystic Ovary Syndrome. 2024. doi: 10.12201/bmr.202411.00004

  Long Yuanyuan, Pu Jiale, Zhang Zengyu, Shen Zihao, Zhang Jidong. ZHANG Jierong1, LONG Yuanyuan1, PU Jiale1, ZHANG Zengyu1,2, SHEN Zihao1, ZHANG Jidong1*(Hunan University of Chinese Medicine,Changsha,410208,China;. 2024. doi: 10.12201/bmr.202409.00005

  Jing ZHAO, Junxia HUANG, Xiuhua TANG, Hong WANG. The role of HOXA11-AS/miR-149-3p pathway in the malignant phenotype of lung squamous cell carcinoma. 2022. doi: 10.12201/bmr.202204.00005

• ID	Submit time	Number	Download
  1	2024-12-11	bmr.202412.00056V1	Download

• Public  Anonymous  To author only Submit Comments